TABLE 3.
Clinical PK models used for simulations
Drugs | PK structure model | Study | Simulated doses | References |
---|---|---|---|---|
B | 3-cmt model with transit absorption | NC-005 Bloading | 400 mg once daily for days 1–14, 200 mg three times per week for days 15–56 | Svensson et al. (14) |
NC-005 Bdaily | 200 mg once daily for 56 days | |||
NC-008 B[200/100] | 200 mg once daily for 56 days, then 100 mg once daily for 63 days | |||
Pa | 1-cmt model with transit absorption and dose-dependent absorption, bioavailability, and volume | NC-002, NC-006 | 100 or 200 mg daily for 56 days or 119 days | Salinger et al. (15) |